REPLIGEN CORP Operating Cash Flow
REPLIGEN CORP (RGEN) reported Operating Cash Flow of $61.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-29
- REPLIGEN CORP net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $32.77M, a 14.53% increase year-over-year.
- REPLIGEN CORP net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $28.30M, a 88.57% increase year-over-year.
- REPLIGEN CORP net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $25.70M, a 34.39% decline year-over-year.
- REPLIGEN CORP net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $48.10M, a 2.48% decline year-over-year.
- REPLIGEN CORP net cash provided by (used in) operating activities for fiscal 2025 was $117.42M, a 33.06% decline from fiscal 2024.
- REPLIGEN CORP net cash provided by (used in) operating activities for fiscal 2024 was $175.39M, a 53.97% increase from fiscal 2023.
- REPLIGEN CORP net cash provided by (used in) operating activities for fiscal 2023 was $113.92M, a 33.80% decline from fiscal 2022.
- REPLIGEN CORP net cash provided by (used in) operating activities for fiscal 2022 was $172.08M, a 44.59% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $32.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $61.06M 10-Q · filed 2026-07-29 | $86.77M derived: sum of 3 quarters · filed 2026-07-29 | $134.86M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $28.30M 10-Q · filed 2026-05-06 | $54.00M derived: sum of 2 quarters · filed 2026-05-06 | $102.10M derived: sum of 3 quarters · filed 2026-05-06 | $130.71M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $25.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $73.80M derived: sum of 2 quarters · filed 2026-02-26 | $102.41M derived: sum of 3 quarters · filed 2026-07-29 | $117.42M 10-K · filed 2026-02-26 |
| 2025-09-30 | $48.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $76.71M derived: sum of 2 quarters · filed 2026-07-29 | $91.71M 10-Q · filed 2025-11-04 | $130.89M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $28.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $43.61M 10-Q · filed 2026-07-29 | $82.79M derived: sum of 3 quarters · filed 2026-07-29 | $132.11M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $15.01M 10-Q · filed 2026-05-06 | $54.18M derived: sum of 2 quarters · filed 2026-05-06 | $103.50M derived: sum of 3 quarters · filed 2026-05-06 | $145.69M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $39.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $88.50M derived: sum of 2 quarters · filed 2026-02-26 | $130.69M derived: sum of 3 quarters · filed 2026-02-26 | $175.39M 10-K · filed 2026-02-26 |
| 2024-09-30 | $49.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $91.51M derived: sum of 2 quarters · filed 2025-11-04 | $136.22M 10-Q · filed 2025-11-04 | $165.28M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $42.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $86.90M 10-Q · filed 2025-08-07 | $115.96M derived: sum of 3 quarters · filed 2026-02-26 | $155.19M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $44.71M 10-Q · filed 2025-04-29 | $73.77M derived: sum of 2 quarters · filed 2026-02-26 | $113.00M derived: sum of 3 quarters · filed 2026-02-26 | $147.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $29.07M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | $68.30M derived: sum of 2 quarters · filed 2026-02-26 | $102.76M derived: sum of 3 quarters · filed 2026-02-26 | $113.92M 10-K · filed 2026-02-26 |
| 2023-09-30 | $39.23M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $73.70M derived: sum of 2 quarters · filed 2024-11-18 | $84.85M 10-Q/A · filed 2024-11-18 | $146.74M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | $34.47M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $45.62M 10-Q/A · filed 2024-11-18 | $107.50M derived: sum of 3 quarters · filed 2025-03-14 | $148.87M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | $11.15M 10-Q/A · filed 2024-11-18 | $73.04M derived: sum of 2 quarters · filed 2025-03-14 | $114.40M derived: sum of 3 quarters · filed 2025-03-14 | $160.12M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | $61.88M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | $103.25M derived: sum of 2 quarters · filed 2025-03-14 | $148.97M derived: sum of 3 quarters · filed 2025-03-14 | $172.08M 10-K · filed 2025-03-14 |
| 2022-09-30 | $41.37M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $87.09M derived: sum of 2 quarters · filed 2024-11-18 | $110.20M 10-Q/A · filed 2024-11-18 | $159.82M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | $45.72M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $68.83M 10-Q/A · filed 2024-11-18 | $118.45M derived: sum of 3 quarters · filed 2024-11-18 | $140.94M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | $23.11M 10-Q/A · filed 2024-11-18 | $72.73M derived: sum of 2 quarters · filed 2024-11-18 | $95.22M derived: sum of 3 quarters · filed 2024-11-18 | $132.87M derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | $49.62M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $72.10M derived: sum of 2 quarters · filed 2024-11-18 | $109.75M derived: sum of 3 quarters · filed 2024-11-18 | $119.02M 10-K/A · filed 2024-11-18 |
| 2021-09-30 | $22.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $60.13M derived: sum of 2 quarters · filed 2022-11-01 | $69.40M 10-Q · filed 2022-11-01 | $84.27M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $37.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $46.91M 10-Q · filed 2022-08-02 | $61.78M derived: sum of 3 quarters · filed 2023-02-22 | $83.27M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $9.26M 10-Q · filed 2022-04-27 | $24.13M derived: sum of 2 quarters · filed 2023-02-22 | $45.62M derived: sum of 3 quarters · filed 2023-02-22 | $62.36M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $14.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $36.36M derived: sum of 2 quarters · filed 2023-02-22 | $53.09M derived: sum of 3 quarters · filed 2023-02-22 | $62.63M 10-K · filed 2023-02-22 |
| 2020-09-30 | $21.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $38.22M derived: sum of 2 quarters · filed 2021-10-28 | $47.75M 10-Q · filed 2021-10-28 | $65.43M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $16.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $26.27M 10-Q · filed 2021-07-27 | $43.94M derived: sum of 3 quarters · filed 2022-02-17 | $65.90M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $9.53M 10-Q · filed 2021-05-04 | $27.20M derived: sum of 2 quarters · filed 2022-02-17 | $49.17M derived: sum of 3 quarters · filed 2022-02-17 | $66.96M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $17.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $39.64M derived: sum of 2 quarters · filed 2022-02-17 | $57.43M derived: sum of 3 quarters · filed 2022-02-17 | $67.22M 10-K · filed 2022-02-17 |
| 2019-09-30 | $21.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $39.75M derived: sum of 2 quarters · filed 2020-11-05 | $49.54M 10-Q · filed 2020-11-05 | $55.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $17.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $27.58M 10-Q · filed 2020-07-30 | $33.13M derived: sum of 3 quarters · filed 2021-02-24 | $52.81M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $9.79M 10-Q · filed 2020-05-06 | $15.34M derived: sum of 2 quarters · filed 2021-02-24 | $35.02M derived: sum of 3 quarters · filed 2021-02-24 | $40.99M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $25.23M derived: sum of 2 quarters · filed 2021-02-24 | $31.20M derived: sum of 3 quarters · filed 2021-02-24 | $32.77M 10-K · filed 2021-02-24 |
| 2018-09-30 | $19.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $25.64M derived: sum of 2 quarters · filed 2019-10-31 | $27.21M 10-Q · filed 2019-10-31 | $42.43M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $5.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $7.54M 10-Q · filed 2019-08-01 | $22.75M derived: sum of 3 quarters · filed 2020-02-26 | $21.02M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $1.57M 10-Q · filed 2019-05-09 | $16.79M derived: sum of 2 quarters · filed 2020-02-26 | $15.06M derived: sum of 3 quarters · filed 2020-02-26 | |
| 2017-12-31 | $15.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $13.49M derived: sum of 2 quarters · filed 2020-02-26 | $17.45M 10-K · filed 2020-02-26 | |
| 2017-09-30 | -$1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $2.23M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $3.96M 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | $7.52M 10-K · filed 2019-03-01 | |||
| 2013-12-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $13.54M derived: sum of 2 quarters · filed 2014-03-14 | $22.34M derived: sum of 3 quarters · filed 2014-03-14 | $25.93M 10-K · filed 2014-03-14 |
| 2013-09-30 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $15.00M derived: sum of 2 quarters · filed 2013-11-08 | $18.59M 10-Q · filed 2013-11-08 | $25.82M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-06-30 | $8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $12.39M 10-Q · filed 2013-08-07 | $19.62M derived: sum of 3 quarters · filed 2014-03-14 | $22.09M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-03-31 | $3.59M 10-Q · filed 2013-05-07 | $10.82M derived: sum of 2 quarters · filed 2014-03-14 | $13.30M derived: sum of 3 quarters · filed 2014-03-14 | $15.30M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-12-31 | $7.23M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $9.70M derived: sum of 2 quarters · filed 2014-03-14 | $11.71M derived: sum of 3 quarters · filed 2014-03-14 | $13.44M 10-K · filed 2014-03-14 |
| 2012-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $4.48M derived: sum of 2 quarters · filed 2013-11-08 | $6.21M 10-Q · filed 2013-11-08 | $11.08M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $3.74M 10-Q · filed 2013-08-07 | $8.61M derived: sum of 3 quarters · filed 2014-03-14 | $8.76M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $1.73M 10-Q · filed 2013-05-07 | $6.61M derived: sum of 2 quarters · filed 2014-03-14 | $6.76M derived: sum of 3 quarters · filed 2014-03-14 | $4.04M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $4.87M derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $5.02M derived: sum of 2 quarters · filed 2014-03-14 | $2.31M 10-K · filed 2014-03-14 | $3.75M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-09-30 | $148.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | -$2.56M 10-Q · filed 2011-11-09 | -$1.12M 10-Q · filed 2012-11-08 | -$4.47K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-06-30 | -$2.71M 10-Q · filed 2011-08-05 | -$1.27M 10-Q · filed 2012-08-09 | -$152.56K derived: sum of 3 quarters · filed 2014-03-14 | $982.52K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-03-31 | $1.44M 10-Q · filed 2012-05-10 | $2.56M derived: sum of 2 quarters · filed 2014-03-14 | $3.69M derived: sum of 3 quarters · filed 2014-03-14 | $3.23M 10-K · filed 2013-03-15 |
| 2010-12-31 | $1.11M derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $2.25M derived: sum of 2 quarters · filed 2014-03-14 | $1.79M 10-K · filed 2014-03-14 | |
| 2010-09-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $673.73K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$461.36K 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | -$2.45M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |